Aerpio Pharmaceuticals names CEO
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Stephen Hoffman will become the CEO of Aerpio Pharmaceuticals Inc. on Dec. 1.
Hoffman succeeds Joseph Gardner, the founder of the company, who will continue to serve as president.
Hoffman joins the company from PDL BioPharma Inc., an investment firm.
